4//SEC Filing
Claypoole Robert E 4
Accession 0001578563-25-000023
CIK 0001665988other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 6:59 PM ET
Size
5.3 KB
Accession
0001578563-25-000023
Insider Transaction Report
Form 4
Claypoole Robert E
DirectorPresident and CEO
Transactions
- Sale
Class A Common Stock
2025-01-13$9.10/sh−28,786$261,953→ 64,964 total
Footnotes (2)
- [F1]Reflects shares sold to cover taxes upon the vesting of restricted stock units on January 10, 2025 pursuant to a standing 10b5-1 instruction adopted on January 11, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.935 to $9.22, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Bioventus Inc.
CIK 0001665988
Entity typeother
Related Parties
1- filerCIK 0002005474
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 6:59 PM ET
- Size
- 5.3 KB